Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Scedosporium apiospermum

ABSTRACT: A colonising microbe but has been identified as a causative pathogen for malignant otitis externa in immunocompromised individuals

PROVIDER: PRJNA322096 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	JOWA01.dat.gz	Other
	JOWA01.fasta.gz	Fasta.gz
	JOWA01.master.dat	Other
	MVOQ01.dat.gz	Other

Items per page:

1 - 5 of 7

Similar Datasets

Project description:Methicillin Resistant Staphylococcus aureus isolated from feline otitis externa

| PRJNA484707 | ENA

Mycobacterium avium subsp. avium ATCC 25291

Project description:Causative agent of mycobacterial disease in children, the aged, and in immunocompromised individuals.

| PRJNA30909 | ENA

Mycobacterium avium 104

Project description:Causative agent of mycobacterial disease in children, the aged, and in immunocompromised individuals.

| PRJNA88 | ENA

Pseudomonas

Project description:Draft Genome Sequences of Pesudomonas species causing Otitis externa infection

| PRJNA695104 | ENA

Vibrio vulnificus

Project description:Pathogen in immunocompromised patients

| PRJNA12341 | ENA

Expression profiles of circRNAs in peripherial blood mononuclear cells from cryptococcal meningitis and healthy individuals.

Project description:CircRNAs are a recently well-known regulator that mediates a variety of biological processes. Cryptococcus neoformans is an environmental fungal pathogen that can cause fatal cryptococcal meningitis in immunocompromised individuals. However, the involvement of circRNA in cryptococcal infection remains unclear. In this study, high‐throughput microarray was performed to identify the circRNA expression profile in cryptococcal meningitis patients.

2020-12-07 | GSE159601 | GEO

Comparative DDA and DIA-PASEF proteomics profiling of cross-kingdom macrophage infection reveals new mechanisms driving pathogen virulence

Project description:Opportunistic infections of the respiratory tract often succeed under a weakened immune response caused by an underlying illness or hospitalization. The human fungal pathogen, Cryptococcus neoformans, and the bacterial pathogen, Klebsiella pneumoniae, are both well-characterized microbes that cause severe infections within immunocompromised individuals. In this study, we simulate a concentration-dependent pulmonary coinfection of a bacterial and fungal pathogen, and profile the proteomic changes by DDA vs. DIA. Dual perspective profiling provides new insights into host defense regulation of infection and pathogenic mechanisms of invasion.

2024-08-13 | PXD054527 | Pride

Transcriptome profile of peripheral blood mononuclear cells in children with acute otitis media caused by Nontypeable Haemophilus influenzae

Project description:Nontypeable Haemophilus influenzae (NTHi) is a common causative organism of acute otitis media (AOM) in children. A human cDNA microarray comprising 30,968 human genome probes was used to evaluate the transcriptional changes that occur in peripheral blood mononuclear cells (PBMC) at the onset of clinical AOM caused by NTHi infection in children after comparison of microarray results with the pre-infection healthy stage of the same children.

2012-03-15 | GSE27990 | GEO

Transcriptome profile of peripheral blood mononuclear cells in children with acute otitis media caused by Streptococcus pneumoniae

Project description:Streptococcus pneumoniae (Spn) is the predominant causative organism of acute otitis media (AOM) in children. A human cDNA microarray comprising 30,968 human genome probes was used to evaluate the transcriptional changes that occur in peripheral blood mononuclear cells (PBMC) at the onset of clinical AOM caused by Spn infection in children after comparison of microarray results with the pre-infection healthy stage of the same children.

2010-07-26 | GSE23140 | GEO

Staphylococcus haemolyticus JCSC1435

Project description:Opportunistic pathogen that affects immunocompromised patients

| PRJNA12508 | ENA